|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-5.58/--
|
企業價值
74.17M
|
資產負債 |
每股賬面淨值
16.89
|
現金流量 |
現金流量率
--
|
損益表 |
收益
21.74M
|
每股收益
22.84
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
![](../images/dot.bmp)
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong. |